Charge‐Reversed Exosomes for Targeted Gene Delivery to Cartilage for Osteoarthritis Treatment
Small Methods · 2024-09 · 8 (9)
DOI: 10.1002/smtd.202301443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, online erschienen am 12.04.2024. Verfasst von Chenzhen Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Northeastern University, Boston, MA, 02115, USA. Hauptthemen laut MEDLINE: Exosomes, Osteoarthritis, Gene Transfer Techniques, Chondrocytes. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIAMS NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Gene therapy has the potential to facilitate targeted expression of therapeutic proteins to promote cartilage regeneration in osteoarthritis (OA). The dense, avascular, aggrecan‐glycosaminoglycan (GAG) rich negatively charged cartilage, however, hinders their transport to reach chondrocytes in effective doses. While viral vector mediated gene delivery has shown promise, concerns over immunogenicity and tumorigenic side‐effects persist. To address these issues, this study develops surface‐modified cartilage‐targeting exosomes as non‐viral carriers for gene therapy. Charge‐reversed cationic exosomes are engineered for mRNA delivery by anchoring cartilage targeting optimally charged arginine‐rich cationic motifs into the anionic exosome bilayer by using buffer pH as a charge‐reversal switch. Cationic exosomes penetrated through the full‐thickness of early‐stage arthritic human cartilage owing to weak‐reversible ionic binding with GAGs and efficiently delivered the encapsulated eGFP mRNA to chondrocytes residing in tissue deep layers, while unmodified anionic exosomes do not. When intra‐articularly injected into destabilized medial meniscus mice knees with early‐stage OA, mRNA loaded charge‐reversed exosomes overcame joint clearance and rapidly penetrated into cartilage, creating an intra‐tissue depot and efficiently expressing eGFP; native exosomes remained unsuccessful. Cationic exosomes thus hold strong translational potential as a platform technology for cartilage‐targeted non‐viral delivery of any relevant mRNA targets for OA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Northeastern University, Boston, MA, 02115, USA.
- Department of Internal Medicine, Division of Rheumatology, Rush University Medical Center, Chicago, IL, 60612, USA.
- Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA.
- Department of Biology, Northeastern University, Boston, MA, 02115, USA.
- Department of Pediatrics, Rush University Medical College, Chicago, IL, 60612, USA.
ORCID-Profile: Ambika G Bajpayee
Förderung
- NIH HHS
- NIAMS NIH HHS
- NIBIB NIH HHS
- National Science Foundation
- National Institutes of Health
- National Institute of Biomedical Imaging and Bioengineering
Zitieren
APA
Zhang, C., Pathrikar, T. V., Baby, H. M., Li, J., Zhang, H., Selvadoss, A., Ovchinnikova, A., Ionescu, A., Chubinskaya, S., Miller, R. E., & Bajpayee, A. G. (2024). Charge‐Reversed Exosomes for Targeted Gene Delivery to Cartilage for Osteoarthritis Treatment. Small Methods, 8(9). https://doi.org/10.1002/smtd.202301443
Vancouver
Zhang C, Pathrikar TV, Baby HM, Li J, Zhang H, Selvadoss A, et al. Charge‐Reversed Exosomes for Targeted Gene Delivery to Cartilage for Osteoarthritis Treatment. Small Methods. 2024;8(9). doi:10.1002/smtd.202301443
BibTeX
@article{Zhang2024,
author = {Zhang, Chenzhen and Pathrikar, Tanvi V and Baby, Helna M and Li, Jun and Zhang, Hengli and Selvadoss, Andrew and Ovchinnikova, Arina and Ionescu, Andreia and Chubinskaya, Susan and Miller, Rachel E and Bajpayee, Ambika G},
title = {Charge‐Reversed Exosomes for Targeted Gene Delivery to Cartilage for Osteoarthritis Treatment},
journal = {Small Methods},
year = {2024},
volume = {8},
number = {9},
doi = {10.1002/smtd.202301443}
}
EUVIMED